| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR561691 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR561752 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR561754 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR561759 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR562005 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR562030 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR562056 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR562058 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR562060 | 5 ug | ORIGENE TECHNOLOGIES |
| Human RNA: Colon; Colitis, ulcerative, chronic active from ORIGENE TECHNOLOGIES | CR562061 | 5 ug | ORIGENE TECHNOLOGIES |
| CD1e molecule (CD1E), transcript variant 3 from ORIGENE TECHNOLOGIES | LY420992 | 100 ug | ORIGENE TECHNOLOGIES |
| CD1e molecule (CD1E), transcript variant 3 from ORIGENE TECHNOLOGIES | LY425779 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartate beta-hydroxylase domain containing 1 (ASPHD1) from ORIGENE TECHNOLOGIES | LY405633 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartate beta-hydroxylase domain containing 2 (ASPHD2) from ORIGENE TECHNOLOGIES | LY412486 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartate dehydrogenase domain containing (ASPDH), transcript variant 1 from ORIGENE TECHNOLOGIES | LY426491 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartate dehydrogenase domain containing (ASPDH), transcript variant 2 from ORIGENE TECHNOLOGIES | LY422526 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartic peptidase, retroviral-like 1 (ASPRV1) from ORIGENE TECHNOLOGIES | LY407282 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartoacylase (aminocyclase) 3 (ACY3) from ORIGENE TECHNOLOGIES | LY408962 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartoacylase (Canavan disease) (ASPA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424954 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartoacylase (Canavan disease) (ASPA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY426889 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartyl aminopeptidase (DNPEP) from ORIGENE TECHNOLOGIES | LY402151 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartylglucosaminidase (AGA), transcript variant 1 from ORIGENE TECHNOLOGIES | LY424971 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartylglucosaminidase (AGA), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432904 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartyl-tRNA synthetase (DARS) from ORIGENE TECHNOLOGIES | LY419995 | 100 ug | ORIGENE TECHNOLOGIES |
| Aspartyl-tRNA synthetase 2, mitochondrial (DARS2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIES | LY413308 | 100 ug | ORIGENE TECHNOLOGIES |
| ASPDH - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN409896 | 1 kit | ORIGENE TECHNOLOGIES |
| Aspdh - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501688 | 1 kit | ORIGENE TECHNOLOGIES |
| ASPDH Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH325390 | 10 ug | ORIGENE TECHNOLOGIES |
| ASPG - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN418090 | 1 kit | ORIGENE TECHNOLOGIES |
| Aspg - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501689 | 1 kit | ORIGENE TECHNOLOGIES |
| ASPG Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH318090 | 10 ug | ORIGENE TECHNOLOGIES |
| ASPHD2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407490 | 1 kit | ORIGENE TECHNOLOGIES |
| ASPHD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN419226 | 1 kit | ORIGENE TECHNOLOGIES |
| Asphd1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501691 | 1 kit | ORIGENE TECHNOLOGIES |
| Asphd2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501692 | 1 kit | ORIGENE TECHNOLOGIES |
| ASPHD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH319226 | 10 ug | ORIGENE TECHNOLOGIES |
| ASPHD2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH307490 | 10 ug | ORIGENE TECHNOLOGIES |
| Dlgap1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504614 | 1 kit | ORIGENE TECHNOLOGIES |
| Dlgap2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504615 | 1 kit | ORIGENE TECHNOLOGIES |
| Dlgap3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504616 | 1 kit | ORIGENE TECHNOLOGIES |
| Dlgap4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504617 | 1 kit | ORIGENE TECHNOLOGIES |
| Dlgap5 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504618 | 1 kit | ORIGENE TECHNOLOGIES |
| DLGAP4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH321038 | 10 ug | ORIGENE TECHNOLOGIES |
| DLG3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN410860 | 1 kit | ORIGENE TECHNOLOGIES |
| DLG5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413793 | 1 kit | ORIGENE TECHNOLOGIES |
| DLG4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415178 | 1 kit | ORIGENE TECHNOLOGIES |
| DLG1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415258 | 1 kit | ORIGENE TECHNOLOGIES |
| DLG2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423915 | 1 kit | ORIGENE TECHNOLOGIES |
| Dlg1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504609 | 1 kit | ORIGENE TECHNOLOGIES |
| Dlg2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN504610 | 1 kit | ORIGENE TECHNOLOGIES |